CAMBRIDGE, Mass., Feb. 02, 2017 -- GCP Applied Technologies, Inc. (NYSE:GCP), a leading global provider of products and technology solutions for the specialty construction chemicals, specialty building materials, and packaging sealants and coatings industries, today announced that it expects to release its fourth quarter 2016 results at 6:00 a.m. ET on Thursday, March 2, 2017. President and Chief Executive Officer Gregory E. Poling and Chief Financial Officer Dean P. Freeman will host a conference call to discuss the results later that day at 10:00 a.m. ET.
The live webcast may be accessed by visiting the “Events and Presentations” section of the company’s website at investor.gcpat.com. The call also may be accessed by dialing +1 (844) 887-9408 in the U.S. or +1 (412) 317-9261 internationally. Participants should ask to join the GCP Applied Technologies earnings call.
For those unable to participate in the live conference call, a playback will be available through March 9, 2017. To listen to the playback, please dial +1 (877) 344-7529 in the U.S. or +1 (412) 317-0088 internationally; the access code is 10099916. A webcast replay will also be available in the “Events and Presentations” section of the company’s website for approximately three months.
About GCP Applied Technologies
GCP Applied Technologies is a leading global provider of products and technology solutions for customers in the specialty construction chemicals, specialty building materials, and packaging sealants and coatings industries. Our products help improve the performance of our customers’ products, increase productivity in their application or manufacturing processes, and meet the increasing regulatory requirements impacting their industry. GCP has approximately 3,000 employees on six continents and serves customers in more than 110 countries. More information is available at www.gcpat.com.
Contacts: Media Relations Paul Keeffe +1 617.498.4461 [email protected] Investor Relations Joe DeCristofaro +1 617.498.2616 [email protected]


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



